Table: Hisamitsu -2019/20 parent results
Apr 10 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Feb 29, 2020 Feb 28, 2019 Feb 28, 2021 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 109.76 109.27
(+0.5 pct) (-2.9 pct)
Operating 20.31 17.79
(+14.2 pct) (-13.8 pct)
Recurring 21.50 19.92
(+8.0 pct) (-6.8 pct)
Net 15.07 15.94
(-5.5 pct) (+9.0 pct)
EPS 183.45 yen 190.96 yen
EPS Diluted 183.23 yen 190.77 yen
Ann Div 83.00 yen 82.50 yen
-Q2 Div 41.50 yen 41.25 yen
-Q4 Div 41.50 yen 41.25 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO